Study for investigating the effects of a probiotic on diarrhea caused by chemotherapy in patients with gastric, colon and rectum cancer
Ontology highlight
ABSTRACT: Primary objectives: The study investigates whether a Escherichia coli Nissle-suspenison has a (preventive) antidiarrheal effect in patients with tumors who are treated with chemotherapeutic schemes which are associated with increased occurances of diarrhea. Diarrhea caused by treatment are thought to be reduced in intensity and/or frequency by the treatment with Escherichia coli Nissle-Suspension.
Primary endpoints: Common toxicity criteria (CTC) for diarrhea
DISEASE(S): Magen- Und Colorectaltumoren, Bei Denen Eine Behandlung Mit 5-fluoruracil Sowie Einem Weiteren Chemotherapeutikum (entweder Irinotecan Oder Ein Platin Basiertes Chemotherapeutikum) Geplant Ist.,Gastric Or Colorectal Cancers, Where A Treatment With 5-fluoruracil And One Further Chemotherapeutic Remedy (either Irinotecan Or A Platinum Based Chemotherapeutic Remedy) Is Planned.
PROVIDER: 2534265 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA